Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30998824 | 1.00 | CA14 (0.42) | CA14MEN1KMT2ATSHRSMN1; SMN2 | |
| SCHEMBL10456801 | 0.84 | ALDH1A1 (0.44) | TSHRSMN1; SMN2ALDH1A1NPSR1LMNA | |
| SCHEMBL7766998 | 0.84 | ALDH1A1 (0.44) | TSHRSMN1; SMN2ALDH1A1NPSR1LMNA | |
| SCHEMBL7424429 | 0.81 | CA12 (0.35) | CA14TSHRSMN1; SMN2MAPT | |
| SCHEMBL7418144 | 0.81 | CA12 (0.35) | CA14TSHRSMN1; SMN2MAPT | |
| SCHEMBL11691480 | 0.81 | — | — | |
| SCHEMBL3205794 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL28264794 | 0.79 | TSHR (0.35) | KMT2ATSHRSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL253527 | 0.78 | — | — | |
| SCHEMBL725364 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1064254-B1 | ALIPHATIC AMINO CARBOXYLIC AND AMINO PHOSPHONIC ACIDS, AMINO NITRILES AND AMINO TETRAZOLES AS CELLULAR RESCUE AGENTS | UNIV SASKATCHEWAN (CA) | 2007-10-17 | — | — | EP | disclosed |
| US-6984754-B1 | Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INC. (CA) | 2006-01-10 | — | — | US | disclosed |
| US-20050159393-A1 | Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INC. (CA) | 2005-07-21 | — | — | US | disclosed |
| EP-0711813-B1 | Antifouling coating composition | HITACHI CHEMICAL CO LTD (JP) | 2001-07-25 | — | — | EP | disclosed |
| US-6231688-B1 | BATH CONTAINING AQUEOUS SOLUTION | HENKEL CORPORATION | 2001-05-15 | — | — | US | disclosed |
| EP-1064254-A2 | ALIPHATIC AMINO CARBOXYLIC AND AMINO PHOSPHONIC ACIDS, AMINO NITRILES AND AMINO TETRAZOLES AS CELLULAR RESCUE AGENTS | University of Saskatchewan Technologies Inc. (CA) | 2001-01-03 | — | — | EP | disclosed |
| WO-1999048858-A2 | ALIPHATIC AMINO CARBOXYLIC AND AMINO PHOSPHONIC ACIDS, AMINO NITRILES AND AMINO TETRAZOLES AS CELLULAR RESCUE AGENTS | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INC. (CA) | 1999-09-30 | — | — | WO | disclosed |
| US-5773508-A | BIODEGRADABLE POLYMER OF ADDITION COPOLYMERS FOR PROTECTIVE COATINGS | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1998-06-30 | — | — | US | disclosed |
| WO-1997020964-A1 | COMPOSITION AND PROCESS FOR ZINC PHOSPHATE CONVERSION COATING | HENKEL CORPORATION (US) | 1997-06-12 | — | — | WO | disclosed |
| EP-0711813-A2 | Coating varnish composition and antifouling coating composition | Hitachi Chemical Co., Ltd. (JP) | 1996-05-15 | — | — | EP | disclosed |
| CN-88101653-A | L-aspartyl-the 3-(bicyclic alkyl) of high sugariness-L-L-Ala alkyl ester | — | 1988-10-26 | — | — | CN | disclosed |
| US-4753957-A | Substituted 2,4-imidazolidinediones and fungicidal compositions | ROHM AND HAAS COMPANY (US) | 1988-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159393-A1 | Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents | CHAMP1, PYCR1, PRMT5 | CA14 2550/4885MEN1 1622/4885KMT2A 3371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.